COL4A1 and gastric neoplasm: Moreover, several immunotherapies based clinical analyses have reported that stromal rich gastric tumors exhibit reduced responses to immune checkpoint inhibitors [96], which supports our observation that COL4A1 and THBS2 correlate with markers of an immune suppressive microenvironment.